Related Experiment Video
Updated: Jun 8, 2026

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Case Report: Mitral Valve Involvement and First-Degree Atrial-Ventricular Block in Two Patients With Multisystem
Paola Di Filippo1, Massimiliano Raso1, Marta Cacciatore1
1Department of Pediatrics, University of Chieti, Chieti, Italy.
Insights
Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare but serious condition following COVID-19. Early treatment with immunoglobulin and steroids shows good outcomes in pediatric patients.
Area of Science:
- Pediatric infectious diseases
- Pediatric critical care medicine
- Immunology
Background:
- COVID-19 is generally less severe in children than adults.
- A hyperinflammatory syndrome, Multisystem Inflammatory Syndrome in Children (MIS-C), emerged in children post-COVID-19.
- MIS-C presents with fever, multiorgan involvement, and requires urgent medical attention.
Observation:
- Two pediatric cases of MIS-C are presented.
- Symptoms included fever, rash, and mild cardiac involvement (mitral valve and AV block).
- Cases followed a paucisymptomatic COVID-19 infection.
Findings:
- Prompt treatment with intravenous immunoglobulin, oral aspirin, and intravenous corticosteroids led to positive outcomes.
- The described cardiac involvement was transient and mild.
- The study highlights effective acute management strategies.
Implications:
- Further research is crucial to understand MIS-C pathogenesis and long-term effects.
- Standardized treatment protocols and therapy tapering guidelines for MIS-C are needed.
- Early recognition and management are key for favorable outcomes in pediatric MIS-C.
Abstract:
COVID-19 seems to be less frequent and severe in children compared to adults. Despite the very few symptoms usually found in children, great attention was recorded when in April 2020 a hyperinflammatory process in children with fever and multiorgan involvement after a paucisymptomatic COVID infection was reported. The United States Centers for Disease Control and the World Health Organization recognized and defined this syndrome as "Multisystem Inflammatory Syndrome in Children (MIS-C)." We describe two cases of MIS-C presenting with fever, cutaneous rash, and a mild cardiac involvement expressed with a transient mitral valve involvement and a first-degree atrioventricular block. Acute treatment was managed with intravenous immunoglobulin, oral aspirin, and intravenous corticosteroids reaching consequent good outcome. Clinical characteristics, treatment management, follow-up, and long-term evolution of children with MIS-C are still poorly defined. Further research is needed to better understand the pathogenesis of this newly described condition, to validate a high-level recommended therapy and a specific therapy tapering timings.
More Related Videos
Related Concept Videos
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

